Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
While these injections can benefit some, they may not be suitable for everyone and can have adverse effects
AOD9604 is bioavailable orally, with MS peptide analysis confirming appearance in pig plasma following oral dosing, and degradation occurring primarily via sequential N-terminal amino acid removal in a cascade fashion
For people with severe deficiencies or who need rapid results, injections are often the best choice
For research purposes only
Hair growth is slow